DE602006009380D1 - Screening verfahren von pet tracers zur fruheren krebs therapeutischen uberwachung - Google Patents

Screening verfahren von pet tracers zur fruheren krebs therapeutischen uberwachung

Info

Publication number
DE602006009380D1
DE602006009380D1 DE602006009380T DE602006009380T DE602006009380D1 DE 602006009380 D1 DE602006009380 D1 DE 602006009380D1 DE 602006009380 T DE602006009380 T DE 602006009380T DE 602006009380 T DE602006009380 T DE 602006009380T DE 602006009380 D1 DE602006009380 D1 DE 602006009380D1
Authority
DE
Germany
Prior art keywords
cancer therapeutic
screening procedure
pet
pet tracers
previous cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006009380T
Other languages
English (en)
Inventor
Mats Bergstrom
Pasha Razifar
Azita Monnazzam
Orjan Lindhe
Raymond Awad
Bengt Langstrom
Raymond Josephsson
Carl Blomqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of DE602006009380D1 publication Critical patent/DE602006009380D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
DE602006009380T 2005-03-21 2006-03-20 Screening verfahren von pet tracers zur fruheren krebs therapeutischen uberwachung Active DE602006009380D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66381805P 2005-03-21 2005-03-21
US71972605P 2005-09-22 2005-09-22
US78226106P 2006-03-14 2006-03-14
PCT/IB2006/000621 WO2006100562A2 (en) 2005-03-21 2006-03-20 Method of screening pet tracers for early cancer thereapy monitoring

Publications (1)

Publication Number Publication Date
DE602006009380D1 true DE602006009380D1 (de) 2009-11-05

Family

ID=36727783

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006009380T Active DE602006009380D1 (de) 2005-03-21 2006-03-20 Screening verfahren von pet tracers zur fruheren krebs therapeutischen uberwachung

Country Status (10)

Country Link
EP (1) EP1861713B1 (de)
AT (1) ATE443868T1 (de)
CY (1) CY1109634T1 (de)
DE (1) DE602006009380D1 (de)
DK (1) DK1861713T3 (de)
ES (1) ES2333669T3 (de)
PL (1) PL1861713T3 (de)
PT (1) PT1861713E (de)
SI (1) SI1861713T1 (de)
WO (1) WO2006100562A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011082191A1 (en) * 2009-12-30 2011-07-07 Ge Healthcare Limited Method of using a 99mtc-labelled injection rgd compound and a [18f]-labelled rgd injection compound in external beam radiotherapy planning
MX2017004810A (es) 2014-10-14 2017-10-16 Novartis Ag Moleculas de anticuerpo que se unen a pd-l1 y usos de las mismas.
CN107847617B (zh) 2015-03-10 2021-08-31 爱默蕾大学 含有取代的亚氨基二乙酸配体的金属三羰基复合物以及作为放射性同位素示踪物的用途
JPWO2019106945A1 (ja) * 2017-11-28 2020-12-17 パナソニックIpマネジメント株式会社 培養状態判定装置、培養状態判定方法及びプログラム
US20240050047A1 (en) * 2020-12-31 2024-02-15 The Board Of Regents Of The University Of Texas System Real-time marker-less dynamic tumor tracking

Also Published As

Publication number Publication date
EP1861713B1 (de) 2009-09-23
DK1861713T3 (da) 2010-01-11
PL1861713T3 (pl) 2010-03-31
ATE443868T1 (de) 2009-10-15
WO2006100562A2 (en) 2006-09-28
CY1109634T1 (el) 2014-08-13
SI1861713T1 (sl) 2010-01-29
ES2333669T3 (es) 2010-02-25
EP1861713A2 (de) 2007-12-05
PT1861713E (pt) 2009-12-24
WO2006100562A3 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
DE602006009380D1 (de) Screening verfahren von pet tracers zur fruheren krebs therapeutischen uberwachung
ATE511885T1 (de) Verfahren zur bestimmung eines interessierenden bereiches von oberflächenstrukturen mit einem dosiervolumenhistogramm
CY1119960T1 (el) Μεθοδοι για την αυξηση της αποτελεσματικοτητας της folr1 θεραπειας του καρκινου
WO2014085826A3 (en) Method for evaluation of presence of or risk of colon tumors
MX2023001945A (es) Composiciones y metodos para el cribado de tumores solidos.
GB2463819A (en) System and process for detecting, tracking and counting human objects of interest
MX2016002051A (es) Metodos y kits para la subtipificacion molecular de tumores.
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
WO2014165022A3 (en) Optical tomography sensor and related apparatus and methods
MY185873A (en) Tracking system and method for use in surveying amusement park equipment
DE102007038392B8 (de) Vorrichtung und Verfahren zur Vorhersage eines Kontrollverlustes über einen Muskel
MX2014013667A (es) Metodos y sistemas para probar materiales de perdida de circulacion.
WO2012154567A3 (en) Human invasion signature for prognosis of metastatic risk
WO2009155096A3 (en) Assessing tumor response to therapy
MX2019007894A (es) Composiciones y metodos para detectar el adn tumoral circulante.
MX2015017950A (es) Metodos para el tratamiento de cancer de ovario.
ATE425699T1 (de) Vorrichtung und verfahren zur erfassung von vorhofflimmern
WO2011051280A8 (en) Ovary tumor markers and methods of use thereof
EP4270007A3 (de) Verwendung von dna-transkriptionsfaktor-komplexen zur krebserkennung
ATE449323T1 (de) Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren
MX2016001948A (es) Método para diagnosticar un tumor pulmonar maligno.
DE502004006670D1 (de) Vorrichtung und verfahren zum nucleophilen fluorieren
ATE496579T1 (de) Verfahren und vorrichtung zur gewinnung eines volumendatensatzes von einem bewegten gewebe oder organ eines patienten
WO2011051271A3 (en) Prostate tumor markers and methods of use thereof
ATE426810T1 (de) Verfahren zum einfachen und schnellen nachweis von zellen und biomolekulen mit hilfe paramagnetischer partikel

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1861713

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB